FindTrial
Sign In

Neutrophil Lymphocyte Ratio (NLR) for Prediction of Mortality in Sepsis patient

Evaluation of Neutrophil Lymphocyte Ratio (NLR) for Prediction of Mortality in Adult Sepsis Patients of ICU - nil

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2024/01/061385
Enrollment
85
Registered
2024-01-11
Start date
Unknown
Completion date
Unknown
Last updated
2024-01-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: D899- Disorder involving the immune mechanism, unspecified

Interventions

Intervention1: NIL: NIL

Sponsors

school of medical sciences and research sharda university
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Age above 18 years 2. Patients of either gender diagnosed of sepsis or septic shock

Exclusion criteria

Exclusion criteria: 1. Pregnant female 2. Non-consenting patients and patient’s attendant 3. Immunocompromized or those with terminal or severe illness (advanced or metastatic cancer, advanced congestive heart failure, stroke, coma)

Design outcomes

Primary

MeasureTime frame
Evaluation of Neutrophil Lymphocyte Ratio (NLR) for Prediction of Mortality in Adult Sepsis Patients of ICUTimepoint: TILL THE PATIENT IS IN ICU or 3 weeks—

Secondary

MeasureTime frame
(1) To calculate NLR ratio of adult sepsis patient in ICU. (2) To estimate APACHE II score to predicted mortality. (3) To find the correlation between NLR & APACHE II score. Timepoint: TILL THE PATIENT IS IN ICU or 3 weeks—

Countries

India

Contacts

Public ContactDr Ram Murti Sharma

school of medical sciences and research sharda university

sharmarammurti@gmail.com7798881243

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026